TERT and neoplasm: Patients with TERT mutations have a significantly higher recurrence rate (p < 0.001, OR = 12.429, OR (95%CI) = 2.805–55.064) and an increased risk of tumor breakthrough of the capsule (p < 0.001, OR = 22.500, OR (95%CI) = 5.078–99.696), as shown in Table 8.